Susana Perez-Gutthann
011-34932417760

Susana Perez-Gutthann

Vice President, Global Head Epidemiology, RTI Health Solutions

Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP, leads a team of 29 epidemiologists and research staff, including senior experts, in the field of pharmacoepidemiology and risk management in RTP (NC, US), Waltham (MA, US), and Barcelona (Spain). Prior positions include global and European head of epidemiology at Pfizer, Pharmacia, Novartis, and Ciba-Geigy.

Dr. Perez-Gutthann has 24 years of experience leading epidemiology teams, and strategy and research programs for safety, pharmacovigilance, and risk management. She is an active leader and past president of the International Society of Pharmacoepidemiology (ISPE); a Fellow of ISPE and of the Royal College of Physicians, Edinburgh; and represents RTI Health Solutions at the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, where she has served as member of the steering group since 2011.

Dr. Perez-Gutthann is the principal investigator of studies and serves as chair or member of advisory boards in pharmacoepidemiology and risk management.

Education

MD, PhD, Universitat de Barcelona; MPH (Postdoctoral fellowship), Epidemiology, The Johns Hopkins University.

Latest Publications

Kaye, J.A., Castellsague, J., Bui, C.L., Calingaert, B., McQuay, L.J., Riera-Guardia, N., Saltus, C.W., Quinlan, S., Holick, C.N., Wahl, P.M., Suzart, K., Rothman, K.J., Wallander, M.-.A., & Perez-Gutthann, S. (2014). Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: A retrospective, population-based cohort study. Pharmacotherapy, 34 (4):336-349.
Kaye, J.A., Castellsague, J., Bui, C.L., Calingaert, B., McQuay, L.J., Riera-Guardia, N., Saltus, C.W., Quinlan, S., Holick, C.N., Wahl, P.M., Suzart, K., Rothman, K.J., Wallander, M.A., & Perez-Gutthann, S. (2014). Risk of Acute Liver Injury Associated with the Use of Moxifloxacin and Other Oral Antimicrobials: A Retrospective, Population-Based Cohort Study. Pharmacotherapy, 34 (4):336-349.
Varas-Lorenzo, C., Castellsague, J., & Perez-Gutthann, S. (2014). Response to the letter to the editor entitled 'Diclofenac: Increase of myocardial infarctions at low doses?' (PDS 13-0441) authored by K Brune. Pharmacoepidemiology and Drug Safety, 23 (3):329-330.
Bui, C.L., Kaye, J.A., Castellsague, J., Calingaert, B., McQuay, L.J., Riera-Guardia, N., Saltus, C.W., Quinlan, S.C., Holick, C.N., Wahl, P.M., Suzart, K., Rothman, K.J., Wallander, M.A., & Perez-Gutthann, S. (2014). Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users. Current Drug Safety, 9 (1):23-28.
Pisa, F., Castellsague, J., Drigo, D., Riera-Guardia, N., Giangreco, M., Rosolen, V., Clagnan, E., Zanier, L., Perez-Gutthann, S., et al. (2013). Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy. Pharmacoepidemiology and Drug Safety, 22 (11):1195-1204.
View all publications by Susana Perez-Gutthann (69)

Expertise